NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

It will be available as an option for people with relapsing-remitting MS (RRMS), the most common form of the condition which ...

Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

Chennai: Caplin Steriles, a Subsidiary Company of Caplin Point Laboratories, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...

Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...